Sinopharm Group Co. Ltd.
SHTDY · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $47,157,104 | $54,313,359 | $43,331,766 | $63,808,538 |
| Short-Term Investments | $0 | $158 | $553 | $547 |
| Receivables | $244,129,499 | $206,721,120 | $242,410,688 | $185,790,359 |
| Inventory | $65,520,380 | $62,352,812 | $68,837,707 | $60,027,648 |
| Other Curr. Assets | $17,090,476 | $24,060,122 | $27,782,110 | $27,208,008 |
| Total Curr. Assets | $373,897,459 | $347,447,571 | $382,362,824 | $336,835,100 |
| Property Plant & Equip (Net) | $15,896,823 | $19,632,440 | $20,098,513 | $19,897,657 |
| Goodwill | $6,202,911 | $6,251,565 | $0 | $7,185,729 |
| Intangibles | $3,997,877 | $4,717,685 | $10,124,033 | $2,830,402 |
| Long-Term Investments | $10,549,621 | $10,894,141 | $10,599,887 | $10,550,686 |
| Tax Assets | $0 | $2,408,387 | $0 | $0 |
| Other NC Assets | $9,623,119 | $1,479,455 | $6,397,860 | $6,095,270 |
| Total NC Assets | $46,270,353 | $45,383,673 | $47,220,293 | $46,559,744 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $420,167,811 | $392,831,244 | $429,583,117 | $383,394,844 |
| Liabilities | – | – | – | – |
| Payables | $152,672,957 | $156,869,715 | $155,834,845 | $154,747,431 |
| Short-Term Debt | $85,913,900 | $64,489,623 | $81,449,561 | $56,526,974 |
| Tax Payable | $0 | $0 | $0 | $2,988,672 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $41,195,524 | $29,016,250 | $45,953,478 | $27,227,560 |
| Total Curr. Liab. | $279,782,381 | $250,375,588 | $283,237,884 | $241,490,637 |
| LT Debt | $7,380,629 | $11,896,511 | $19,605,663 | $17,254,878 |
| Deferred Rev, NC | $0 | $0 | $0 | $448,241 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $788,379 |
| Other NC Liab. | $3,532,479 | $3,871,843 | $4,306,634 | $3,093,964 |
| Total NC Liab. | $10,913,108 | $15,768,354 | $23,912,297 | $21,585,462 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $2,945,054 | $5,019,855 | $5,441,084 | $5,217,366 |
| Total Liabilities | $290,695,489 | $266,143,942 | $307,150,181 | $263,076,099 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $3,120,656 | $3,120,656 | $3,120,656 | $3,120,656 |
| Retained Earnings | $56,791,247 | $53,744,881 | $50,398,964 | $49,410,060 |
| AOCI | $20,190 | $22,022,096 | $22,026,173 | $0 |
| Other Equity | $20,449,821 | -$3,838 | -$3,838 | $22,051,501 |
| Total Equity | $80,381,914 | $78,883,795 | $75,541,955 | $74,582,217 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $49,090,409 | $47,803,507 | $46,890,981 | $45,736,528 |
| Total Liab. & Tot. Equity | $420,167,811 | $392,831,244 | $429,583,117 | $383,394,844 |
| Net Debt | $46,137,425 | $22,072,775 | $57,723,458 | $9,973,314 |